Concepedia
Statistics
Publications
23
Citations
603
H-Index
17
Active since
2011
Affiliations
Virginia Commonwealth University(Current)
Saint Louis University
University of Messina
Tianjin Medical University
Albert Einstein College of Medicine
Christopher K. Arnatt is an author at Virginia Commonwealth University specializing in pharmacology, medicine, and drug discovery.
Publications per year
2011–2022
Sphingosine-1-phosphate receptor 1 activation in the central nervous system drives cisplatin-induced cognitive impairment
Silvia Squillace, Michael L. Niehoff, Timothy M. Doyle et al. · Journal of Clinical Investigation · 2022 · 49 citations · Full text
Medicine, Neuroscience, Pharmacology +17
Activation of Estrogen Receptor G Protein–Coupled Receptor 30 Enhances Cholesterol Cholelithogenesis in Female Mice
Helen H. Wang, Ornella de Bari, Christopher K. Arnatt et al. · Hepatology · 2020 · 43 citations · Full text
Life Sciences, Endocrinology, Pharmacology +17
G Protein‐Coupled Estrogen Receptor (GPER) Agonist Dual Binding Mode Analyses Toward Understanding of Its Activation Mechanism: A Comparative Homology Modeling Approach
Christopher K. Arnatt, Yan Zhang · Molecular Informatics · 2013 · 38 citations · Full text
Medicine, Medicinal Chemistry, Pharmacology +17
A bivalent ligand targeting the putative mu opioid receptor and chemokine receptor CCR5 heterodimer: binding affinity versus functional activities
Yunyun Yuan, Christopher K. Arnatt, Nazira El‐Hage et al. · MedChemComm · 2013 · 36 citations · Full text
Design and synthesis of a bivalent ligand to explore the putative heterodimerization of the mu opioid receptor and the chemokine receptor CCR5
Yunyun Yuan, Christopher K. Arnatt, Li Guo et al. · Organic & Biomolecular Chemistry · 2012 · 35 citations
1–5 of 23